Comment on "On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Retinoid signaling in skeletal development: Scoping the system for predictive toxicology.Reproductive toxicology (Elmsford, N.Y.) · 2021
   Review
2. Potential of ToxCast Data in the Safety Assessment of Food Chemicals.Toxicological sciences : an official journal of the Society of Toxicology · 2020
   Article
3. Comparison of transcriptome responses to glyphosate, isoxaflutole, quizalofop-p-ethyl and mesotrione in the HepaRG cell line.Toxicology reports · 2018
   Article

Corrections and comments

• Commented on by
  Reply to "Comment on 'On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens'".2017
• Comment on
  On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens.2016

Authors and funding

10 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as